Reata Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Reata Pharmaceuticals

Access the complete profile.

Reata Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	5320 Legacy Drive Plano, TX 75024

Note: Revenues for privately held companies are statistical evaluations.


Reata Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Reata Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Reata Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Reata Pharmaceuticals Annual Revenue and Growth Rate

Reata Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Reata Pharmaceuticals's revenues are gauged from an analysis of company filings.

Reata Pharmaceuticals's Income Statement (based on Industry Averages)

Reata Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Reata Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
June 25, 2020	2	100%	$50 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Reata Pharmaceuticals is developing and marketing. Reata Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
R REACH REATA EDUCATION, ACCESS & CARE HELPLINE Providing patient advocate and support services for patients undergoing medical treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy	07/11/2023
REATAREACH Providing patient advocate and support services for patients undergoing medical treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy	07/11/2023
REATA REACH Providing patient advocate and support services for patients undergoing medical treatment of neurological, neuromuscular, neuropsychiatric, psychiatric, mitochondrial, ophthalmological, cardiovascular, renal, autoimmune, gastrointestinal, metabolic, seizure, and dermatological diseases and disorders, and epilepsy	07/11/2023

See all trademarks and details in the Full Report.

Market Share of Reata Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Reata Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Reata Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REATA PHARMACEUTICALS	Plano, TX	100
UNITED LABORATORIES MANUFACTURING	Carrollton, TX	73
NEOS THERAPEUTICS	Grand Prairie, TX	24
PREMARK HEALTH SCIENCE	Irving, TX	18
COSMAX NBT USA	Garland, TX	16
BIO-SYNTHESIS	Lewisville, TX	12

Future Competition: Reata Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Reata Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)